A pharmacist-led intervention targeted towards reducing the prevalence of sedative prescription in aged care has reduced antipsychotic prescribing by 13% and that of benzodiazepines...
Endometriosis can result in reduced quality of life and significant burden to the health system.
This evidence summary presents the best available evidence regarding the...
Thalidomide’s period of use may have been short but its ramifications have lasted decades, both for people who suffer deformities from its effects and...
Fewer than half of all Australians can correctly identify asthma as a chronic disease that doesn’t go away, according to new Asthma Australia research.¹
In...
With medication issues the top cause of complaints in aged care homes (ACH), we examine attitudes towards the current services, and canvass possibilities for...
The TGA has approved a new preventative treatment for migraine, with a new medicine that targets the calcitonin gene-related peptide receptor.
Patients experiencing migraine will...
Despite an increase in anticonvulsant use for back and neck pain recently - an increase of 535% in the last 10 years - researchers...
Scenario
A patient, who identifies as an Aboriginal person, presents to the pharmacy for her monthly prescriptions. Her prescriptions are not annotated as ‘CTG -...
There is rising concern over the side effects of long-term proton pump inhibitor (PPI) use but limited evidence to warrant discontinuation, a literature review...
Around one in 16 Australians will suffer from depression at some time during their life.1,2 What evidence is there that complementary medicines such as S-Adenosyl-L-methionine...
